nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—SCN7A—myometrium—ovarian cancer	0.0112	0.0954	CbGeAlD
Rufinamide—GRM5—female reproductive system—ovarian cancer	0.0103	0.0881	CbGeAlD
Rufinamide—GRM5—testis—ovarian cancer	0.00833	0.0711	CbGeAlD
Rufinamide—SCN7A—female reproductive system—ovarian cancer	0.00651	0.0556	CbGeAlD
Rufinamide—SCN7A—female gonad—ovarian cancer	0.00593	0.0506	CbGeAlD
Rufinamide—SCN7A—testis—ovarian cancer	0.00526	0.0449	CbGeAlD
Rufinamide—SCN8A—testis—ovarian cancer	0.00469	0.04	CbGeAlD
Rufinamide—SCN3A—decidua—ovarian cancer	0.0045	0.0384	CbGeAlD
Rufinamide—SCN9A—testis—ovarian cancer	0.00412	0.0351	CbGeAlD
Rufinamide—CES1—female reproductive system—ovarian cancer	0.00407	0.0347	CbGeAlD
Rufinamide—SCN7A—lymph node—ovarian cancer	0.00381	0.0325	CbGeAlD
Rufinamide—CES1—female gonad—ovarian cancer	0.0037	0.0316	CbGeAlD
Rufinamide—SCN4A—testis—ovarian cancer	0.00367	0.0314	CbGeAlD
Rufinamide—SCN2A—vagina—ovarian cancer	0.00364	0.0311	CbGeAlD
Rufinamide—SCN3A—female reproductive system—ovarian cancer	0.00354	0.0302	CbGeAlD
Rufinamide—SCN3A—bone marrow—ovarian cancer	0.00334	0.0285	CbGeAlD
Rufinamide—CES1—testis—ovarian cancer	0.00328	0.028	CbGeAlD
Rufinamide—SCN3A—vagina—ovarian cancer	0.0032	0.0273	CbGeAlD
Rufinamide—SCN5A—vagina—ovarian cancer	0.00319	0.0273	CbGeAlD
Rufinamide—SCN9A—lymph node—ovarian cancer	0.00299	0.0255	CbGeAlD
Rufinamide—SCN3A—testis—ovarian cancer	0.00286	0.0244	CbGeAlD
Rufinamide—CES1—lymph node—ovarian cancer	0.00238	0.0203	CbGeAlD
Rufinamide—ALB—testis—ovarian cancer	0.00228	0.0195	CbGeAlD
Rufinamide—SCN10A—lymph node—ovarian cancer	0.00227	0.0194	CbGeAlD
Rufinamide—Infection—Vinorelbine—ovarian cancer	0.00208	0.00285	CcSEcCtD
Rufinamide—SCN3A—lymph node—ovarian cancer	0.00207	0.0177	CbGeAlD
Rufinamide—Sinusitis—Paclitaxel—ovarian cancer	0.00207	0.00284	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00207	0.00284	CcSEcCtD
Rufinamide—Fatigue—Melphalan—ovarian cancer	0.00207	0.00284	CcSEcCtD
Rufinamide—Nervous system disorder—Vinorelbine—ovarian cancer	0.00205	0.00282	CcSEcCtD
Rufinamide—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00205	0.00281	CcSEcCtD
Rufinamide—Skin disorder—Vinorelbine—ovarian cancer	0.00203	0.00279	CcSEcCtD
Rufinamide—Hypersensitivity—Chlorambucil—ovarian cancer	0.00203	0.00278	CcSEcCtD
Rufinamide—Anorexia—Vinorelbine—ovarian cancer	0.002	0.00274	CcSEcCtD
Rufinamide—Rhinitis—Paclitaxel—ovarian cancer	0.00199	0.00273	CcSEcCtD
Rufinamide—Asthenia—Chlorambucil—ovarian cancer	0.00197	0.00271	CcSEcCtD
Rufinamide—Neutropenia—Docetaxel—ovarian cancer	0.00196	0.00269	CcSEcCtD
Rufinamide—Urinary tract disorder—Paclitaxel—ovarian cancer	0.00196	0.00269	CcSEcCtD
Rufinamide—Pruritus—Chlorambucil—ovarian cancer	0.00194	0.00267	CcSEcCtD
Rufinamide—Urethral disorder—Paclitaxel—ovarian cancer	0.00194	0.00267	CcSEcCtD
Rufinamide—Lymphadenopathy—Epirubicin—ovarian cancer	0.00192	0.00263	CcSEcCtD
Rufinamide—Weight decreased—Docetaxel—ovarian cancer	0.0019	0.00261	CcSEcCtD
Rufinamide—Pneumonia—Docetaxel—ovarian cancer	0.00188	0.00258	CcSEcCtD
Rufinamide—Diarrhoea—Chlorambucil—ovarian cancer	0.00188	0.00258	CcSEcCtD
Rufinamide—Infestation NOS—Docetaxel—ovarian cancer	0.00187	0.00257	CcSEcCtD
Rufinamide—Infestation—Docetaxel—ovarian cancer	0.00187	0.00257	CcSEcCtD
Rufinamide—Eye disorder—Paclitaxel—ovarian cancer	0.00185	0.00254	CcSEcCtD
Rufinamide—Cardiac disorder—Paclitaxel—ovarian cancer	0.00184	0.00252	CcSEcCtD
Rufinamide—Decreased appetite—Vinorelbine—ovarian cancer	0.00182	0.0025	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00181	0.00248	CcSEcCtD
Rufinamide—Fatigue—Vinorelbine—ovarian cancer	0.0018	0.00248	CcSEcCtD
Rufinamide—Hypersensitivity—Topotecan—ovarian cancer	0.0018	0.00247	CcSEcCtD
Rufinamide—Constipation—Vinorelbine—ovarian cancer	0.00179	0.00246	CcSEcCtD
Rufinamide—Immune system disorder—Paclitaxel—ovarian cancer	0.00179	0.00246	CcSEcCtD
Rufinamide—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00179	0.00245	CcSEcCtD
Rufinamide—Lymphadenopathy—Doxorubicin—ovarian cancer	0.00178	0.00244	CcSEcCtD
Rufinamide—Hepatobiliary disease—Docetaxel—ovarian cancer	0.00177	0.00243	CcSEcCtD
Rufinamide—Hypersensitivity—Melphalan—ovarian cancer	0.00177	0.00242	CcSEcCtD
Rufinamide—Epistaxis—Docetaxel—ovarian cancer	0.00176	0.00242	CcSEcCtD
Rufinamide—Asthenia—Topotecan—ovarian cancer	0.00176	0.00241	CcSEcCtD
Rufinamide—Vomiting—Chlorambucil—ovarian cancer	0.00175	0.0024	CcSEcCtD
Rufinamide—Increased appetite—Epirubicin—ovarian cancer	0.00174	0.00239	CcSEcCtD
Rufinamide—Mental disorder—Paclitaxel—ovarian cancer	0.00174	0.00238	CcSEcCtD
Rufinamide—Pruritus—Topotecan—ovarian cancer	0.00173	0.00238	CcSEcCtD
Rufinamide—Malnutrition—Paclitaxel—ovarian cancer	0.00173	0.00237	CcSEcCtD
Rufinamide—Asthenia—Melphalan—ovarian cancer	0.00172	0.00236	CcSEcCtD
Rufinamide—Pruritus—Melphalan—ovarian cancer	0.0017	0.00233	CcSEcCtD
Rufinamide—Rhinitis—Docetaxel—ovarian cancer	0.00168	0.00231	CcSEcCtD
Rufinamide—Diarrhoea—Topotecan—ovarian cancer	0.00167	0.0023	CcSEcCtD
Rufinamide—CYP2E1—female reproductive system—ovarian cancer	0.00167	0.0143	CbGeAlD
Rufinamide—Back pain—Paclitaxel—ovarian cancer	0.00167	0.00229	CcSEcCtD
Rufinamide—Urinary tract disorder—Docetaxel—ovarian cancer	0.00166	0.00228	CcSEcCtD
Rufinamide—ALB—lymph node—ovarian cancer	0.00165	0.0141	CbGeAlD
Rufinamide—Urethral disorder—Docetaxel—ovarian cancer	0.00165	0.00226	CcSEcCtD
Rufinamide—Diarrhoea—Melphalan—ovarian cancer	0.00164	0.00225	CcSEcCtD
Rufinamide—Diplopia—Epirubicin—ovarian cancer	0.00164	0.00225	CcSEcCtD
Rufinamide—Nausea—Chlorambucil—ovarian cancer	0.00163	0.00224	CcSEcCtD
Rufinamide—Vision blurred—Paclitaxel—ovarian cancer	0.00163	0.00223	CcSEcCtD
Rufinamide—Dizziness—Topotecan—ovarian cancer	0.00162	0.00222	CcSEcCtD
Rufinamide—Tremor—Paclitaxel—ovarian cancer	0.00162	0.00222	CcSEcCtD
Rufinamide—Increased appetite—Doxorubicin—ovarian cancer	0.00161	0.00221	CcSEcCtD
Rufinamide—Anaemia—Paclitaxel—ovarian cancer	0.00159	0.00219	CcSEcCtD
Rufinamide—Agitation—Paclitaxel—ovarian cancer	0.00159	0.00218	CcSEcCtD
Rufinamide—Eye disorder—Docetaxel—ovarian cancer	0.00157	0.00215	CcSEcCtD
Rufinamide—Cardiac disorder—Docetaxel—ovarian cancer	0.00156	0.00214	CcSEcCtD
Rufinamide—Vomiting—Topotecan—ovarian cancer	0.00156	0.00214	CcSEcCtD
Rufinamide—Vertigo—Paclitaxel—ovarian cancer	0.00155	0.00213	CcSEcCtD
Rufinamide—Leukopenia—Paclitaxel—ovarian cancer	0.00154	0.00212	CcSEcCtD
Rufinamide—Rash—Topotecan—ovarian cancer	0.00154	0.00212	CcSEcCtD
Rufinamide—Hypersensitivity—Vinorelbine—ovarian cancer	0.00154	0.00212	CcSEcCtD
Rufinamide—Dermatitis—Topotecan—ovarian cancer	0.00154	0.00212	CcSEcCtD
Rufinamide—Ataxia—Epirubicin—ovarian cancer	0.00154	0.00211	CcSEcCtD
Rufinamide—Headache—Topotecan—ovarian cancer	0.00153	0.0021	CcSEcCtD
Rufinamide—Vomiting—Melphalan—ovarian cancer	0.00152	0.00209	CcSEcCtD
Rufinamide—Immune system disorder—Docetaxel—ovarian cancer	0.00152	0.00208	CcSEcCtD
Rufinamide—Diplopia—Doxorubicin—ovarian cancer	0.00152	0.00208	CcSEcCtD
Rufinamide—Mediastinal disorder—Docetaxel—ovarian cancer	0.00151	0.00208	CcSEcCtD
Rufinamide—Rash—Melphalan—ovarian cancer	0.00151	0.00207	CcSEcCtD
Rufinamide—Dermatitis—Melphalan—ovarian cancer	0.00151	0.00207	CcSEcCtD
Rufinamide—Asthenia—Vinorelbine—ovarian cancer	0.0015	0.00206	CcSEcCtD
Rufinamide—Abdominal pain upper—Epirubicin—ovarian cancer	0.0015	0.00205	CcSEcCtD
Rufinamide—Convulsion—Paclitaxel—ovarian cancer	0.00149	0.00205	CcSEcCtD
Rufinamide—Pruritus—Vinorelbine—ovarian cancer	0.00148	0.00203	CcSEcCtD
Rufinamide—Breast disorder—Epirubicin—ovarian cancer	0.00148	0.00203	CcSEcCtD
Rufinamide—Mental disorder—Docetaxel—ovarian cancer	0.00147	0.00202	CcSEcCtD
Rufinamide—Nasopharyngitis—Epirubicin—ovarian cancer	0.00146	0.00201	CcSEcCtD
Rufinamide—Anxiety—Paclitaxel—ovarian cancer	0.00146	0.00201	CcSEcCtD
Rufinamide—Malnutrition—Docetaxel—ovarian cancer	0.00146	0.00201	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00146	0.002	CcSEcCtD
Rufinamide—Nausea—Topotecan—ovarian cancer	0.00145	0.00199	CcSEcCtD
Rufinamide—Diarrhoea—Vinorelbine—ovarian cancer	0.00143	0.00197	CcSEcCtD
Rufinamide—Ataxia—Doxorubicin—ovarian cancer	0.00142	0.00196	CcSEcCtD
Rufinamide—Nausea—Melphalan—ovarian cancer	0.00142	0.00195	CcSEcCtD
Rufinamide—Influenza—Epirubicin—ovarian cancer	0.00142	0.00194	CcSEcCtD
Rufinamide—Back pain—Docetaxel—ovarian cancer	0.00141	0.00194	CcSEcCtD
Rufinamide—Infection—Paclitaxel—ovarian cancer	0.0014	0.00192	CcSEcCtD
Rufinamide—Dizziness—Vinorelbine—ovarian cancer	0.00138	0.0019	CcSEcCtD
Rufinamide—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00138	0.0019	CcSEcCtD
Rufinamide—Nervous system disorder—Paclitaxel—ovarian cancer	0.00138	0.0019	CcSEcCtD
Rufinamide—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00138	0.00189	CcSEcCtD
Rufinamide—Breast disorder—Doxorubicin—ovarian cancer	0.00137	0.00188	CcSEcCtD
Rufinamide—Skin disorder—Paclitaxel—ovarian cancer	0.00137	0.00188	CcSEcCtD
Rufinamide—Bronchitis—Epirubicin—ovarian cancer	0.00136	0.00187	CcSEcCtD
Rufinamide—Nasopharyngitis—Doxorubicin—ovarian cancer	0.00136	0.00186	CcSEcCtD
Rufinamide—Anaemia—Docetaxel—ovarian cancer	0.00135	0.00186	CcSEcCtD
Rufinamide—CYP2E1—testis—ovarian cancer	0.00135	0.0115	CbGeAlD
Rufinamide—CYP3A4—female reproductive system—ovarian cancer	0.00135	0.0115	CbGeAlD
Rufinamide—Anorexia—Paclitaxel—ovarian cancer	0.00134	0.00184	CcSEcCtD
Rufinamide—Vomiting—Vinorelbine—ovarian cancer	0.00133	0.00183	CcSEcCtD
Rufinamide—Dysuria—Epirubicin—ovarian cancer	0.00132	0.00182	CcSEcCtD
Rufinamide—Neutropenia—Epirubicin—ovarian cancer	0.00132	0.00182	CcSEcCtD
Rufinamide—Rash—Vinorelbine—ovarian cancer	0.00132	0.00181	CcSEcCtD
Rufinamide—Dermatitis—Vinorelbine—ovarian cancer	0.00132	0.00181	CcSEcCtD
Rufinamide—Headache—Vinorelbine—ovarian cancer	0.00131	0.0018	CcSEcCtD
Rufinamide—Influenza—Doxorubicin—ovarian cancer	0.00131	0.0018	CcSEcCtD
Rufinamide—Leukopenia—Docetaxel—ovarian cancer	0.00131	0.0018	CcSEcCtD
Rufinamide—Pollakiuria—Epirubicin—ovarian cancer	0.00131	0.00179	CcSEcCtD
Rufinamide—Weight decreased—Epirubicin—ovarian cancer	0.00128	0.00176	CcSEcCtD
Rufinamide—Insomnia—Paclitaxel—ovarian cancer	0.00127	0.00175	CcSEcCtD
Rufinamide—Pneumonia—Epirubicin—ovarian cancer	0.00127	0.00174	CcSEcCtD
Rufinamide—Convulsion—Docetaxel—ovarian cancer	0.00127	0.00174	CcSEcCtD
Rufinamide—Infestation—Epirubicin—ovarian cancer	0.00126	0.00173	CcSEcCtD
Rufinamide—Infestation NOS—Epirubicin—ovarian cancer	0.00126	0.00173	CcSEcCtD
Rufinamide—Bronchitis—Doxorubicin—ovarian cancer	0.00126	0.00173	CcSEcCtD
Rufinamide—Somnolence—Paclitaxel—ovarian cancer	0.00125	0.00172	CcSEcCtD
Rufinamide—Nausea—Vinorelbine—ovarian cancer	0.00124	0.00171	CcSEcCtD
Rufinamide—Dyspepsia—Paclitaxel—ovarian cancer	0.00124	0.0017	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00124	0.0017	CcSEcCtD
Rufinamide—Dysuria—Doxorubicin—ovarian cancer	0.00122	0.00168	CcSEcCtD
Rufinamide—Neutropenia—Doxorubicin—ovarian cancer	0.00122	0.00168	CcSEcCtD
Rufinamide—Decreased appetite—Paclitaxel—ovarian cancer	0.00122	0.00168	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00122	0.00167	CcSEcCtD
Rufinamide—Fatigue—Paclitaxel—ovarian cancer	0.00121	0.00167	CcSEcCtD
Rufinamide—Pollakiuria—Doxorubicin—ovarian cancer	0.00121	0.00166	CcSEcCtD
Rufinamide—Constipation—Paclitaxel—ovarian cancer	0.0012	0.00165	CcSEcCtD
Rufinamide—Haematuria—Epirubicin—ovarian cancer	0.0012	0.00165	CcSEcCtD
Rufinamide—Hepatobiliary disease—Epirubicin—ovarian cancer	0.00119	0.00164	CcSEcCtD
Rufinamide—Epistaxis—Epirubicin—ovarian cancer	0.00119	0.00163	CcSEcCtD
Rufinamide—Infection—Docetaxel—ovarian cancer	0.00119	0.00163	CcSEcCtD
Rufinamide—Weight decreased—Doxorubicin—ovarian cancer	0.00118	0.00163	CcSEcCtD
Rufinamide—Sinusitis—Epirubicin—ovarian cancer	0.00118	0.00163	CcSEcCtD
Rufinamide—Pneumonia—Doxorubicin—ovarian cancer	0.00117	0.00161	CcSEcCtD
Rufinamide—Nervous system disorder—Docetaxel—ovarian cancer	0.00117	0.00161	CcSEcCtD
Rufinamide—Thrombocytopenia—Docetaxel—ovarian cancer	0.00117	0.0016	CcSEcCtD
Rufinamide—Infestation NOS—Doxorubicin—ovarian cancer	0.00117	0.0016	CcSEcCtD
Rufinamide—Infestation—Doxorubicin—ovarian cancer	0.00117	0.0016	CcSEcCtD
Rufinamide—Skin disorder—Docetaxel—ovarian cancer	0.00116	0.00159	CcSEcCtD
Rufinamide—Anorexia—Docetaxel—ovarian cancer	0.00114	0.00156	CcSEcCtD
Rufinamide—Rhinitis—Epirubicin—ovarian cancer	0.00114	0.00156	CcSEcCtD
Rufinamide—Urinary tract disorder—Epirubicin—ovarian cancer	0.00112	0.00154	CcSEcCtD
Rufinamide—Haematuria—Doxorubicin—ovarian cancer	0.00111	0.00153	CcSEcCtD
Rufinamide—Urethral disorder—Epirubicin—ovarian cancer	0.00111	0.00152	CcSEcCtD
Rufinamide—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.0011	0.00152	CcSEcCtD
Rufinamide—Epistaxis—Doxorubicin—ovarian cancer	0.0011	0.00151	CcSEcCtD
Rufinamide—Sinusitis—Doxorubicin—ovarian cancer	0.0011	0.0015	CcSEcCtD
Rufinamide—Insomnia—Docetaxel—ovarian cancer	0.00108	0.00148	CcSEcCtD
Rufinamide—Somnolence—Docetaxel—ovarian cancer	0.00106	0.00146	CcSEcCtD
Rufinamide—Eye disorder—Epirubicin—ovarian cancer	0.00106	0.00145	CcSEcCtD
Rufinamide—Cardiac disorder—Epirubicin—ovarian cancer	0.00105	0.00144	CcSEcCtD
Rufinamide—Rhinitis—Doxorubicin—ovarian cancer	0.00105	0.00144	CcSEcCtD
Rufinamide—Dyspepsia—Docetaxel—ovarian cancer	0.00105	0.00144	CcSEcCtD
Rufinamide—Decreased appetite—Docetaxel—ovarian cancer	0.00104	0.00142	CcSEcCtD
Rufinamide—Hypersensitivity—Paclitaxel—ovarian cancer	0.00104	0.00142	CcSEcCtD
Rufinamide—Urinary tract disorder—Doxorubicin—ovarian cancer	0.00104	0.00142	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00103	0.00141	CcSEcCtD
Rufinamide—Fatigue—Docetaxel—ovarian cancer	0.00103	0.00141	CcSEcCtD
Rufinamide—Urethral disorder—Doxorubicin—ovarian cancer	0.00103	0.00141	CcSEcCtD
Rufinamide—Immune system disorder—Epirubicin—ovarian cancer	0.00102	0.0014	CcSEcCtD
Rufinamide—Mediastinal disorder—Epirubicin—ovarian cancer	0.00102	0.0014	CcSEcCtD
Rufinamide—Constipation—Docetaxel—ovarian cancer	0.00102	0.0014	CcSEcCtD
Rufinamide—Asthenia—Paclitaxel—ovarian cancer	0.00101	0.00139	CcSEcCtD
Rufinamide—Pruritus—Paclitaxel—ovarian cancer	0.000996	0.00137	CcSEcCtD
Rufinamide—Mental disorder—Epirubicin—ovarian cancer	0.000993	0.00136	CcSEcCtD
Rufinamide—Malnutrition—Epirubicin—ovarian cancer	0.000986	0.00135	CcSEcCtD
Rufinamide—Eye disorder—Doxorubicin—ovarian cancer	0.00098	0.00134	CcSEcCtD
Rufinamide—Cardiac disorder—Doxorubicin—ovarian cancer	0.000973	0.00134	CcSEcCtD
Rufinamide—Diarrhoea—Paclitaxel—ovarian cancer	0.000963	0.00132	CcSEcCtD
Rufinamide—Back pain—Epirubicin—ovarian cancer	0.000954	0.00131	CcSEcCtD
Rufinamide—Immune system disorder—Doxorubicin—ovarian cancer	0.000947	0.0013	CcSEcCtD
Rufinamide—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000945	0.0013	CcSEcCtD
Rufinamide—Dizziness—Paclitaxel—ovarian cancer	0.000931	0.00128	CcSEcCtD
Rufinamide—Vision blurred—Epirubicin—ovarian cancer	0.000929	0.00128	CcSEcCtD
Rufinamide—Mental disorder—Doxorubicin—ovarian cancer	0.000918	0.00126	CcSEcCtD
Rufinamide—Malnutrition—Doxorubicin—ovarian cancer	0.000913	0.00125	CcSEcCtD
Rufinamide—Anaemia—Epirubicin—ovarian cancer	0.000912	0.00125	CcSEcCtD
Rufinamide—Agitation—Epirubicin—ovarian cancer	0.000906	0.00124	CcSEcCtD
Rufinamide—Vomiting—Paclitaxel—ovarian cancer	0.000895	0.00123	CcSEcCtD
Rufinamide—Rash—Paclitaxel—ovarian cancer	0.000888	0.00122	CcSEcCtD
Rufinamide—Dermatitis—Paclitaxel—ovarian cancer	0.000887	0.00122	CcSEcCtD
Rufinamide—Vertigo—Epirubicin—ovarian cancer	0.000886	0.00122	CcSEcCtD
Rufinamide—Leukopenia—Epirubicin—ovarian cancer	0.000883	0.00121	CcSEcCtD
Rufinamide—Back pain—Doxorubicin—ovarian cancer	0.000883	0.00121	CcSEcCtD
Rufinamide—Headache—Paclitaxel—ovarian cancer	0.000882	0.00121	CcSEcCtD
Rufinamide—Hypersensitivity—Docetaxel—ovarian cancer	0.000879	0.00121	CcSEcCtD
Rufinamide—Vision blurred—Doxorubicin—ovarian cancer	0.00086	0.00118	CcSEcCtD
Rufinamide—Asthenia—Docetaxel—ovarian cancer	0.000856	0.00118	CcSEcCtD
Rufinamide—Convulsion—Epirubicin—ovarian cancer	0.000855	0.00117	CcSEcCtD
Rufinamide—Pruritus—Docetaxel—ovarian cancer	0.000844	0.00116	CcSEcCtD
Rufinamide—Anaemia—Doxorubicin—ovarian cancer	0.000843	0.00116	CcSEcCtD
Rufinamide—Agitation—Doxorubicin—ovarian cancer	0.000839	0.00115	CcSEcCtD
Rufinamide—Anxiety—Epirubicin—ovarian cancer	0.000837	0.00115	CcSEcCtD
Rufinamide—Nausea—Paclitaxel—ovarian cancer	0.000836	0.00115	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000834	0.00114	CcSEcCtD
Rufinamide—Vertigo—Doxorubicin—ovarian cancer	0.00082	0.00113	CcSEcCtD
Rufinamide—Leukopenia—Doxorubicin—ovarian cancer	0.000817	0.00112	CcSEcCtD
Rufinamide—Diarrhoea—Docetaxel—ovarian cancer	0.000817	0.00112	CcSEcCtD
Rufinamide—Infection—Epirubicin—ovarian cancer	0.0008	0.0011	CcSEcCtD
Rufinamide—Convulsion—Doxorubicin—ovarian cancer	0.000791	0.00109	CcSEcCtD
Rufinamide—Nervous system disorder—Epirubicin—ovarian cancer	0.000789	0.00108	CcSEcCtD
Rufinamide—Dizziness—Docetaxel—ovarian cancer	0.000789	0.00108	CcSEcCtD
Rufinamide—Thrombocytopenia—Epirubicin—ovarian cancer	0.000788	0.00108	CcSEcCtD
Rufinamide—Skin disorder—Epirubicin—ovarian cancer	0.000782	0.00107	CcSEcCtD
Rufinamide—Anxiety—Doxorubicin—ovarian cancer	0.000774	0.00106	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000772	0.00106	CcSEcCtD
Rufinamide—Anorexia—Epirubicin—ovarian cancer	0.000767	0.00105	CcSEcCtD
Rufinamide—Vomiting—Docetaxel—ovarian cancer	0.000759	0.00104	CcSEcCtD
Rufinamide—Rash—Docetaxel—ovarian cancer	0.000752	0.00103	CcSEcCtD
Rufinamide—Dermatitis—Docetaxel—ovarian cancer	0.000752	0.00103	CcSEcCtD
Rufinamide—Headache—Docetaxel—ovarian cancer	0.000748	0.00103	CcSEcCtD
Rufinamide—Infection—Doxorubicin—ovarian cancer	0.00074	0.00102	CcSEcCtD
Rufinamide—Nervous system disorder—Doxorubicin—ovarian cancer	0.00073	0.001	CcSEcCtD
Rufinamide—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000729	0.001	CcSEcCtD
Rufinamide—Insomnia—Epirubicin—ovarian cancer	0.000728	0.000999	CcSEcCtD
Rufinamide—Skin disorder—Doxorubicin—ovarian cancer	0.000723	0.000993	CcSEcCtD
Rufinamide—Somnolence—Epirubicin—ovarian cancer	0.000716	0.000982	CcSEcCtD
Rufinamide—Anorexia—Doxorubicin—ovarian cancer	0.00071	0.000974	CcSEcCtD
Rufinamide—Nausea—Docetaxel—ovarian cancer	0.000709	0.000973	CcSEcCtD
Rufinamide—Dyspepsia—Epirubicin—ovarian cancer	0.000709	0.000973	CcSEcCtD
Rufinamide—Decreased appetite—Epirubicin—ovarian cancer	0.0007	0.00096	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000695	0.000954	CcSEcCtD
Rufinamide—Fatigue—Epirubicin—ovarian cancer	0.000694	0.000953	CcSEcCtD
Rufinamide—Constipation—Epirubicin—ovarian cancer	0.000688	0.000945	CcSEcCtD
Rufinamide—Insomnia—Doxorubicin—ovarian cancer	0.000674	0.000925	CcSEcCtD
Rufinamide—Somnolence—Doxorubicin—ovarian cancer	0.000662	0.000909	CcSEcCtD
Rufinamide—Dyspepsia—Doxorubicin—ovarian cancer	0.000656	0.0009	CcSEcCtD
Rufinamide—Decreased appetite—Doxorubicin—ovarian cancer	0.000647	0.000889	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000643	0.000883	CcSEcCtD
Rufinamide—Fatigue—Doxorubicin—ovarian cancer	0.000642	0.000881	CcSEcCtD
Rufinamide—Constipation—Doxorubicin—ovarian cancer	0.000637	0.000874	CcSEcCtD
Rufinamide—Hypersensitivity—Epirubicin—ovarian cancer	0.000593	0.000814	CcSEcCtD
Rufinamide—Asthenia—Epirubicin—ovarian cancer	0.000578	0.000793	CcSEcCtD
Rufinamide—Pruritus—Epirubicin—ovarian cancer	0.000569	0.000782	CcSEcCtD
Rufinamide—Diarrhoea—Epirubicin—ovarian cancer	0.000551	0.000756	CcSEcCtD
Rufinamide—Hypersensitivity—Doxorubicin—ovarian cancer	0.000549	0.000753	CcSEcCtD
Rufinamide—Asthenia—Doxorubicin—ovarian cancer	0.000534	0.000733	CcSEcCtD
Rufinamide—Dizziness—Epirubicin—ovarian cancer	0.000532	0.000731	CcSEcCtD
Rufinamide—Pruritus—Doxorubicin—ovarian cancer	0.000527	0.000723	CcSEcCtD
Rufinamide—Vomiting—Epirubicin—ovarian cancer	0.000512	0.000702	CcSEcCtD
Rufinamide—Diarrhoea—Doxorubicin—ovarian cancer	0.00051	0.000699	CcSEcCtD
Rufinamide—Rash—Epirubicin—ovarian cancer	0.000508	0.000697	CcSEcCtD
Rufinamide—Dermatitis—Epirubicin—ovarian cancer	0.000507	0.000696	CcSEcCtD
Rufinamide—Headache—Epirubicin—ovarian cancer	0.000504	0.000692	CcSEcCtD
Rufinamide—Dizziness—Doxorubicin—ovarian cancer	0.000493	0.000676	CcSEcCtD
Rufinamide—Nausea—Epirubicin—ovarian cancer	0.000478	0.000656	CcSEcCtD
Rufinamide—Vomiting—Doxorubicin—ovarian cancer	0.000474	0.00065	CcSEcCtD
Rufinamide—Rash—Doxorubicin—ovarian cancer	0.00047	0.000645	CcSEcCtD
Rufinamide—Dermatitis—Doxorubicin—ovarian cancer	0.000469	0.000644	CcSEcCtD
Rufinamide—Headache—Doxorubicin—ovarian cancer	0.000467	0.00064	CcSEcCtD
Rufinamide—Nausea—Doxorubicin—ovarian cancer	0.000442	0.000607	CcSEcCtD
Rufinamide—SCN2A—Developmental Biology—MMP9—ovarian cancer	0.000143	0.00093	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—HRAS—ovarian cancer	0.000142	0.00092	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—VEGFA—ovarian cancer	0.000141	0.000916	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—CTNNB1—ovarian cancer	0.000141	0.000915	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—CTNNB1—ovarian cancer	0.000141	0.000915	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ESR1—ovarian cancer	0.00014	0.00091	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—VEGFA—ovarian cancer	0.00014	0.000909	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—IL6—ovarian cancer	0.00014	0.000908	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—STAT3—ovarian cancer	0.000139	0.0009	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—NRAS—ovarian cancer	0.000138	0.000898	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—MMP9—ovarian cancer	0.000138	0.000897	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—MMP9—ovarian cancer	0.000138	0.000897	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL6ST—ovarian cancer	0.000138	0.000895	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—HRAS—ovarian cancer	0.000137	0.000888	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—MMP9—ovarian cancer	0.000136	0.000884	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—IL6—ovarian cancer	0.000136	0.000881	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—HRAS—ovarian cancer	0.000136	0.00088	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—AKT1—ovarian cancer	0.000136	0.00088	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—ovarian cancer	0.000135	0.000873	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—VEGFA—ovarian cancer	0.000134	0.000869	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—STAT3—ovarian cancer	0.000133	0.000861	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PIK3CG—ovarian cancer	0.000133	0.00086	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—APC—ovarian cancer	0.000133	0.00086	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—NRAS—ovarian cancer	0.000133	0.00086	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—MAPK3—ovarian cancer	0.000133	0.00086	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—NRAS—ovarian cancer	0.000132	0.000859	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NME2—ovarian cancer	0.000132	0.000853	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—IL6—ovarian cancer	0.000131	0.00085	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—HRAS—ovarian cancer	0.00013	0.000846	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—HRAS—ovarian cancer	0.00013	0.000846	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—IL6—ovarian cancer	0.00013	0.000843	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MMP2—ovarian cancer	0.000129	0.000839	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—VEGFA—ovarian cancer	0.000129	0.000835	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—VEGFA—ovarian cancer	0.000129	0.000835	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—STAT3—ovarian cancer	0.000128	0.000827	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—STAT3—ovarian cancer	0.000128	0.000827	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000128	0.000827	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—NRAS—ovarian cancer	0.000127	0.000825	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—NRAS—ovarian cancer	0.000127	0.000825	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—MAPK3—ovarian cancer	0.000127	0.000824	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—MAPK3—ovarian cancer	0.000127	0.000822	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—MAPK1—ovarian cancer	0.000126	0.000818	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—EGFR—ovarian cancer	0.000126	0.000818	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—HRAS—ovarian cancer	0.000126	0.000816	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—HRAS—ovarian cancer	0.000126	0.000816	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—HRAS—ovarian cancer	0.000125	0.000812	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—IL6—ovarian cancer	0.000125	0.000809	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—IL6—ovarian cancer	0.000125	0.000809	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TP53—ovarian cancer	0.000125	0.000807	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—VEGFA—ovarian cancer	0.000124	0.000805	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—VEGFA—ovarian cancer	0.000124	0.000805	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—STAT3—ovarian cancer	0.000123	0.000797	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—STAT3—ovarian cancer	0.000123	0.000797	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—NRAS—ovarian cancer	0.000123	0.000795	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—NRAS—ovarian cancer	0.000123	0.000795	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—VEGFA—ovarian cancer	0.000122	0.000793	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—MAPK3—ovarian cancer	0.000122	0.00079	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—MAPK3—ovarian cancer	0.000122	0.00079	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—AKT1—ovarian cancer	0.000121	0.000784	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—MAPK1—ovarian cancer	0.000121	0.000784	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—NRAS—ovarian cancer	0.000121	0.000784	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—EGFR—ovarian cancer	0.000121	0.000784	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—MAPK1—ovarian cancer	0.000121	0.000782	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—EGFR—ovarian cancer	0.000121	0.000782	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—IL6—ovarian cancer	0.00012	0.000781	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—IL6—ovarian cancer	0.00012	0.000781	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—IL6—ovarian cancer	0.00012	0.000777	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—KRAS—ovarian cancer	0.000119	0.000773	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—MAPK3—ovarian cancer	0.000118	0.000762	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—MAPK3—ovarian cancer	0.000118	0.000762	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PIK3CD—ovarian cancer	0.000117	0.000756	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.000117	0.000755	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—MAPK1—ovarian cancer	0.000116	0.000752	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—MAPK1—ovarian cancer	0.000116	0.000752	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—EGFR—ovarian cancer	0.000116	0.000752	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—EGFR—ovarian cancer	0.000116	0.000752	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—MAPK3—ovarian cancer	0.000116	0.000751	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000116	0.000749	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000115	0.000745	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—KRAS—ovarian cancer	0.000114	0.00074	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—IL6—ovarian cancer	0.000114	0.000739	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—KRAS—ovarian cancer	0.000114	0.000739	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—ERBB2—ovarian cancer	0.000113	0.000735	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—MAPK1—ovarian cancer	0.000112	0.000725	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—MAPK1—ovarian cancer	0.000112	0.000725	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—EGFR—ovarian cancer	0.000112	0.000725	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—EGFR—ovarian cancer	0.000112	0.000725	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SPARC—ovarian cancer	0.000112	0.000724	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000112	0.000724	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—AKT1—ovarian cancer	0.000111	0.000717	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—MAPK1—ovarian cancer	0.00011	0.000714	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—EGFR—ovarian cancer	0.00011	0.000714	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—KRAS—ovarian cancer	0.00011	0.00071	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—KRAS—ovarian cancer	0.00011	0.00071	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—KRAS—ovarian cancer	0.000106	0.000685	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—KRAS—ovarian cancer	0.000106	0.000685	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—PIK3CA—ovarian cancer	0.000105	0.00068	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	0.000105	0.00068	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—KRAS—ovarian cancer	0.000104	0.000675	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ERBB2—ovarian cancer	0.000103	0.000668	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PIK3CB—ovarian cancer	0.000102	0.000659	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MTOR—ovarian cancer	0.000102	0.000659	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—HRAS—ovarian cancer	0.000101	0.000657	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—CTNNB1—ovarian cancer	9.92e-05	0.000643	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYTB—ovarian cancer	9.87e-05	0.00064	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CXCL8—ovarian cancer	9.77e-05	0.000633	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MMP9—ovarian cancer	9.73e-05	0.000631	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—HRAS—ovarian cancer	9.71e-05	0.000629	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—IL6—ovarian cancer	9.7e-05	0.000629	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—HRAS—ovarian cancer	9.69e-05	0.000628	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CDKN1B—ovarian cancer	9.54e-05	0.000618	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—AKT1—ovarian cancer	9.44e-05	0.000612	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CASP3—ovarian cancer	9.35e-05	0.000606	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL2—ovarian cancer	9.34e-05	0.000605	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—HRAS—ovarian cancer	9.31e-05	0.000604	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—HRAS—ovarian cancer	9.31e-05	0.000604	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—IL6—ovarian cancer	9.29e-05	0.000602	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—IL6—ovarian cancer	9.28e-05	0.000601	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	9.22e-05	0.000597	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CCND1—ovarian cancer	9.1e-05	0.00059	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	9.1e-05	0.00059	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—IL6—ovarian cancer	9.06e-05	0.000587	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CTNNB1—ovarian cancer	9.01e-05	0.000584	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—HRAS—ovarian cancer	8.98e-05	0.000582	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—HRAS—ovarian cancer	8.98e-05	0.000582	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—AKT1—ovarian cancer	8.95e-05	0.00058	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—IL6—ovarian cancer	8.91e-05	0.000578	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—IL6—ovarian cancer	8.91e-05	0.000578	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—HRAS—ovarian cancer	8.85e-05	0.000573	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MMP9—ovarian cancer	8.84e-05	0.000573	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PTEN—ovarian cancer	8.79e-05	0.000569	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—VEGFA—ovarian cancer	8.73e-05	0.000566	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—STAT3—ovarian cancer	8.65e-05	0.000561	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—NRAS—ovarian cancer	8.63e-05	0.000559	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PPP1CC—ovarian cancer	8.62e-05	0.000559	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—BRIP1—ovarian cancer	8.62e-05	0.000559	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—IL6—ovarian cancer	8.59e-05	0.000557	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—IL6—ovarian cancer	8.59e-05	0.000557	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—AKT1—ovarian cancer	8.57e-05	0.000556	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—AKT1—ovarian cancer	8.56e-05	0.000555	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	8.51e-05	0.000552	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYTB—ovarian cancer	8.48e-05	0.00055	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—IL6—ovarian cancer	8.47e-05	0.000549	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	8.29e-05	0.000537	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MAPK3—ovarian cancer	8.26e-05	0.000536	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—AKT1—ovarian cancer	8.22e-05	0.000533	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—AKT1—ovarian cancer	8.22e-05	0.000533	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	8.22e-05	0.000533	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SOD1—ovarian cancer	8.11e-05	0.000526	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PPP2R1A—ovarian cancer	8.07e-05	0.000523	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	8.03e-05	0.000521	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—VEGFA—ovarian cancer	7.94e-05	0.000514	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—AKT1—ovarian cancer	7.93e-05	0.000514	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—AKT1—ovarian cancer	7.93e-05	0.000514	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MAPK1—ovarian cancer	7.86e-05	0.00051	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—EGFR—ovarian cancer	7.86e-05	0.00051	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—STAT3—ovarian cancer	7.86e-05	0.000509	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NRAS—ovarian cancer	7.84e-05	0.000508	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MAPK3—ovarian cancer	7.51e-05	0.000487	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—KRAS—ovarian cancer	7.43e-05	0.000481	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PPP1CC—ovarian cancer	7.41e-05	0.00048	CbGpPWpGaD
Rufinamide—ALB—Metabolism—BRIP1—ovarian cancer	7.41e-05	0.00048	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	7.38e-05	0.000478	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MYC—ovarian cancer	7.3e-05	0.000473	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MAPK1—ovarian cancer	7.14e-05	0.000463	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EGFR—ovarian cancer	7.14e-05	0.000463	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NME2—ovarian cancer	7.1e-05	0.00046	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—KRAS—ovarian cancer	6.75e-05	0.000437	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	6.49e-05	0.000421	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—HRAS—ovarian cancer	6.31e-05	0.000409	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	6.27e-05	0.000406	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PIK3CA—ovarian cancer	6.2e-05	0.000402	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—IL6—ovarian cancer	6.04e-05	0.000392	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TP53—ovarian cancer	6e-05	0.000389	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CAV1—ovarian cancer	5.93e-05	0.000385	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	5.93e-05	0.000384	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—YAP1—ovarian cancer	5.78e-05	0.000375	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HRAS—ovarian cancer	5.73e-05	0.000372	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	5.64e-05	0.000366	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—AKT1—ovarian cancer	5.57e-05	0.000361	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL6—ovarian cancer	5.49e-05	0.000356	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CG—ovarian cancer	5.4e-05	0.00035	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.4e-05	0.00035	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—AKT1—ovarian cancer	5.06e-05	0.000328	CbGpPWpGaD
Rufinamide—ALB—Metabolism—YAP1—ovarian cancer	4.97e-05	0.000322	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.92e-05	0.000319	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	4.9e-05	0.000317	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CD—ovarian cancer	4.75e-05	0.000308	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—FASN—ovarian cancer	4.72e-05	0.000306	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC5A5—ovarian cancer	4.64e-05	0.000301	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYTB—ovarian cancer	4.58e-05	0.000297	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC2A1—ovarian cancer	4.48e-05	0.00029	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.33e-05	0.00028	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP1B1—ovarian cancer	4.29e-05	0.000278	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CB—ovarian cancer	4.14e-05	0.000268	CbGpPWpGaD
Rufinamide—ALB—Metabolism—FASN—ovarian cancer	4.05e-05	0.000263	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—BRIP1—ovarian cancer	4e-05	0.000259	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PPP1CC—ovarian cancer	4e-05	0.000259	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	4e-05	0.000259	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC5A5—ovarian cancer	3.99e-05	0.000258	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC2A1—ovarian cancer	3.85e-05	0.00025	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	3.81e-05	0.000247	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IL2—ovarian cancer	3.8e-05	0.000247	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.77e-05	0.000244	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP1B1—ovarian cancer	3.69e-05	0.000239	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ABCB1—ovarian cancer	3.54e-05	0.000229	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TYMS—ovarian cancer	3.47e-05	0.000225	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PPP2R1A—ovarian cancer	3.27e-05	0.000212	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.26e-05	0.000211	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VEGFA—ovarian cancer	3.23e-05	0.000209	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NRAS—ovarian cancer	3.19e-05	0.000207	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MAPK3—ovarian cancer	3.06e-05	0.000198	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCB1—ovarian cancer	3.04e-05	0.000197	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TYMS—ovarian cancer	2.99e-05	0.000193	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MAPK1—ovarian cancer	2.91e-05	0.000189	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CAV1—ovarian cancer	2.8e-05	0.000181	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—KRAS—ovarian cancer	2.75e-05	0.000178	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—YAP1—ovarian cancer	2.68e-05	0.000174	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CG—ovarian cancer	2.55e-05	0.000165	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CA—ovarian cancer	2.52e-05	0.000164	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TP53—ovarian cancer	2.44e-05	0.000158	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CAV1—ovarian cancer	2.41e-05	0.000156	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—HRAS—ovarian cancer	2.34e-05	0.000151	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.3e-05	0.000149	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CD—ovarian cancer	2.24e-05	0.000145	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CG—ovarian cancer	2.19e-05	0.000142	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—FASN—ovarian cancer	2.19e-05	0.000142	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC5A5—ovarian cancer	2.15e-05	0.000139	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.08e-05	0.000135	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—AKT1—ovarian cancer	2.06e-05	0.000134	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.99e-05	0.000129	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CB—ovarian cancer	1.95e-05	0.000127	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CD—ovarian cancer	1.93e-05	0.000125	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.77e-05	0.000115	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTEN—ovarian cancer	1.69e-05	0.000109	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CB—ovarian cancer	1.68e-05	0.000109	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.64e-05	0.000106	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TYMS—ovarian cancer	1.61e-05	0.000104	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTEN—ovarian cancer	1.45e-05	9.4e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CAV1—ovarian cancer	1.3e-05	8.42e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CA—ovarian cancer	1.19e-05	7.72e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.18e-05	7.67e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.04e-05	6.74e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CA—ovarian cancer	1.02e-05	6.63e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKT1—ovarian cancer	9.73e-06	6.31e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CB—ovarian cancer	9.06e-06	5.87e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKT1—ovarian cancer	8.36e-06	5.42e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTEN—ovarian cancer	7.83e-06	5.08e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CA—ovarian cancer	5.52e-06	3.58e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKT1—ovarian cancer	4.51e-06	2.93e-05	CbGpPWpGaD
